We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

YSS:NYSEYork Space Systems Inc. Analysis

Data as of 2026-05-12 - not real-time

$35.88

Latest Price

8/10Risk

Risk Level: High

Executive Summary

York Space Systems (YSS) is trading at $35.88, comfortably above its 20‑day, 50‑day and 200‑day moving averages, indicating a bullish price trend despite a neutral RSI of 55.5. The technical picture is mixed, with a bearish MACD crossover and a shrinking volume trend, while the 30‑day volatility is extremely high at roughly 148% and the beta of 2.24 signals strong sensitivity to market swings. On the fundamentals side, revenue surged 37.5% year‑over‑year, yet the company remains loss‑making with negative operating and profit margins, a debt‑to‑equity ratio of 17.3, and cash flow deficits that outweigh its cash reserves. Valuation metrics are stretched: a forward P/E of 63 far exceeds the industry average of 30, and the price‑to‑sales multiple sits near 12, while the upside‑downside projection offers only a modest 1.26× upside. Analyst sentiment is bullish (“buy”) and the Fear & Greed Index sits at an “Extreme Greed” 88.6, suggesting market enthusiasm ahead of the upcoming Q1 2026 earnings release on May 14. In summary, YSS presents a growth‑oriented narrative with strong top‑line momentum but is weighed down by profitability challenges, high leverage, and elevated market risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD crossover and decreasing volume
  • Extreme short‑term volatility and high beta
  • Price already above key support levels

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Robust 37.5% revenue growth trajectory
  • Upcoming earnings release that could clarify profitability
  • Improved relative strength rating and analyst buy consensus

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Strategic position in the expanding space‑defense market
  • Long‑term government contracts and satellite platform portfolio
  • Growth‑oriented valuation despite current earnings deficits

Key Metrics & Analysis

Financial Health

Revenue Growth37.50%
Profit Margin-21.89%
P/E Ratio63.4
ROE-9.10%
ROA-2.62%
Debt/Equity17.32
P/B Ratio2.1
Op. Cash Flow$-121330000
Free Cash Flow$-65135248
Industry P/E30.2

Technical Analysis

TrendBullish
RSI55.5
Support$28.50
Resistance$44.54
MA 20$35.14
MA 50$28.24
MA 200$27.94
MACDBearish
VolumeDecreasing
Fear & Greed Index88.61

Valuation

Target Price$36.33
Upside/Downside1.26%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta2.24
Volatility147.98%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.